Cardiology Now

ODYSSEY Outcomes: Alirocumab Reduces CV Outcomes and All-Cause Mortality in ACS Patients

Informações:

Synopsis

Dr. Schwartz and Dr. Gibson Discuss Subscribe on iTunes or Google Play.